{"nct_id":"NCT02793583","title":"Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma","status":"TERMINATED","status_verified_date":"2022-07","start_date":"2016-05-25","start_date_type":"ACTUAL","primary_completion_date":"2022-05-31","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-04","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["TGTX"]}